The Future of 340B: Rebates, Regulations, and Rural Healthcare at Risk
In this special episode of The ASHHRA Podcast, co-hosts Bo Brabo and Luke Carignan welcome RxBenefits Strategic Hospital Advisors Sarah Hearn, MPH, and Sarah McHale, as well as 340B expert Rhiannon Klein, to break down HRSA’s proposed 340B rebate model and what it could mean for hospital funding, workforce resources, and the long-term sustainability of rural healthcare.
This episode covers:
- How the proposed rebate model could expand to cover more drugs and reduce 340B benefits
- Why new data reporting requirements could increase operational risk and manufacturer leverage
- How changes in Medicaid eligibility may directly impact 340B participation and hospital funding
- Why the future of rural healthcare hinges on protecting access to 340B savings amid rising financial strain
Why This Matters for HR Leaders
The proposed shift in 340B reimbursement isn’t just a finance issue – it’s a workforce issue. Reduced savings may limit hospital resources, impact benefits, and disrupt care access for the communities you serve. With HRSA accepting public comments through Sept. 2, healthcare HR leaders have an opportunity to stay informed, support internal alignment, and make their voices heard.
Listen now to understand the policy changes, the risks ahead, and how HR can help protect hospital sustainability.
Discover more about 340B and access expert insights.
Check out how RxBenefits’ 340B tools can help covered entities maximize their savings.
Is there a 340B topic you want to know more about? Make your suggestion here!
You Might Also Enjoy

The Battle Over 340B Drug Pricing (Part 2)
The Battle Over 340B Drug Pricing (Part 2) Explore the complexities and upcoming changes to 340B with RxBenefits and the…

Why HR Leaders Should Care About 340B
Why HR Leaders Should Care About 340B As the second-largest federal drug program in the U.S., the 340B program plays…